Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma

被引:194
作者
Glas, Annuska M.
Knoops, Laurent
Delahaye, Leonie
Kersten, Marie Jose
Kibbelaar, Robby E.
Wessels, Lodewyk A.
van Laar, Ryan
van Krieken, J. Han J. M.
Baars, Joke W.
Raemaekers, John
Kluin, Philip M.
van 't Veer, Laura J.
de Jong, Daphne
机构
[1] Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands
[2] Netherlands Canc Inst, Dept Med Hematol Oncol, NL-1066 CX Amsterdam, Netherlands
[3] Agendia BV, Amsterdam, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Dept Hematol, NL-1105 AZ Amsterdam, Netherlands
[5] Cent Labs, Dept Pathol, Friesland, Netherlands
[6] Radboud Univ Med Ctr Nijmegen, Dept Pathol, Nijmegen, Netherlands
[7] Radboud Univ Med Ctr Nijmegen, Dept Hematol, Nijmegen, Netherlands
[8] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol, Groningen, Netherlands
[9] Univ Catholique Louvain, Expt Med Unit, Louvain, Belgium
关键词
D O I
10.1200/JCO.2006.06.1648
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Despite the generally favorable clinical course in follicular lymphoma (FL), a minority of patients have a poor prognosis - with death within 3 years of diagnosis - most often due to transformation to aggressive disease. Patients and Methods In this study, we analyzed the potential of predicting early transformation on the basis of gene expression and immunologic parameters in FL biopsy samples taken at diagnosis. Results At the gene-expression level, FL is a highly uniform disease at the time of diagnosis, precluding the detection of sufficiently validated prognostic gene-expression profiles suitable for a clinical setting. Combinations of differentially expressed genes indicate that immunologic mechanisms play a differential role in the risk of early transformation. Using immunohistochemistry for specific cell populations, the spatial distribution to neoplastic follicles and the activation of CD4-positive T-helper cells (P = .002) and specifically T-helper 1 (P = .004) were shown to be highly discriminatory to predict early transformation. A role for functional modulation of follicular dendritic cells could also be supported (P = .04). Other cell populations, including CD68-positive macrophages and regulatory T cells, were not differentially present. Conclusion These results support the identification of FL as an immunologically functional disease in which an interaction of the tumor cells and the functional composition of the microenvironment determines the clinical behavior.
引用
收藏
页码:390 / 398
页数:9
相关论文
共 31 条
  • [1] Semi-supervised methods to predict patient survival from gene expression data
    Bair, E
    Tibshirani, R
    [J]. PLOS BIOLOGY, 2004, 2 (04) : 511 - 522
  • [2] Variation in gene expression patterns in follicular lymphoma and the response to rituximab
    Bohen, SP
    Troyanskaya, OG
    Alter, O
    Warnke, R
    Botstein, D
    Brown, PO
    Levy, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (04) : 1926 - 1930
  • [3] Minimum information about a microarray experiment (MIAME) - toward standards for microarray data
    Brazma, A
    Hingamp, P
    Quackenbush, J
    Sherlock, G
    Spellman, P
    Stoeckert, C
    Aach, J
    Ansorge, W
    Ball, CA
    Causton, HC
    Gaasterland, T
    Glenisson, P
    Holstege, FCP
    Kim, IF
    Markowitz, V
    Matese, JC
    Parkinson, H
    Robinson, A
    Sarkans, U
    Schulze-Kremer, S
    Stewart, J
    Taylor, R
    Vilo, J
    Vingron, M
    [J]. NATURE GENETICS, 2001, 29 (04) : 365 - 371
  • [4] Chan WC, 1997, BLOOD, V89, P3909
  • [5] Germinal centre-like versus undifferentiated stromal immunophenotypes in follicular lymphoma
    Chang, KC
    Huang, XL
    Medeiros, LJ
    Jones, D
    [J]. JOURNAL OF PATHOLOGY, 2003, 201 (03) : 404 - 412
  • [6] Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells
    Dave, SS
    Wright, G
    Tan, B
    Rosenwald, A
    Gascoyne, RD
    Chan, WC
    Fisher, RI
    Braziel, RM
    Rimsza, LM
    Grogan, TM
    Miller, TP
    LeBlanc, M
    Greiner, TC
    Weisenburger, DD
    Lynch, JC
    Vose, J
    Armitage, JO
    Smeland, EB
    Kvaloy, S
    Holte, H
    Delabie, J
    Connors, JM
    Lansdorp, PM
    Ouyang, Q
    Lister, TA
    Davies, AJ
    Norton, AJ
    Muller-Hermelink, HK
    Ott, G
    Campo, E
    Montserrat, E
    Wilson, WH
    Jaffe, ES
    Simon, R
    Yang, LM
    Powell, J
    Zhao, H
    Goldschmidt, N
    Chiorazzi, M
    Staudt, LM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (21) : 2159 - 2169
  • [8] VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia
    Egle, A
    Harris, AW
    Bath, ML
    O'Reilly, L
    Cory, S
    [J]. BLOOD, 2004, 103 (06) : 2276 - 2283
  • [9] Follicular lymphoma cell lines, an in vitro model for antigenic selection and cytokine-mediated growth regulation of germinal centre B cells
    Eray, M
    Postila, V
    Eeva, J
    Ripatti, A
    Karjalainen-Lindsberg, ML
    Knuutila, S
    Andersson, LC
    Pelkonen, J
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2003, 57 (06) : 545 - 555
  • [10] Analysis of multiple biomarkers, shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)
    Farinha, P
    Masoudi, H
    Skinnider, BF
    Shumansky, K
    Spinelli, JJ
    Gill, K
    Klasa, R
    Voss, N
    Connors, JM
    Gascoyne, RD
    [J]. BLOOD, 2005, 106 (06) : 2169 - 2174